CCEL
AMEX · Health Care
Cryo-Cell Intl Inc
$3.28
-0.04 (-1.20%)
Financial Highlights (FY 2026)
Revenue
31.51M
Net Income
-2,425,405
Gross Margin
76.6%
Profit Margin
-7.7%
Rev Growth
+1.3%
D/E Ratio
0.45
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 76.6% | 76.6% | 58.0% | 58.0% |
| Operating Margin | 1.5% | 1.4% | 14.0% | 13.9% |
| Profit Margin | -7.7% | -7.3% | 13.7% | 12.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 31.51M | 31.10M | 7.57M | 7.87M |
| Gross Profit | 24.15M | 23.83M | 4.39M | 4.56M |
| Operating Income | 482.2K | 428.2K | 1.06M | 1.09M |
| Net Income | -2,425,405 | -2,154,213 | 1.04M | 986.8K |
| Gross Margin | 76.6% | 76.6% | 58.0% | 58.0% |
| Operating Margin | 1.5% | 1.4% | 14.0% | 13.9% |
| Profit Margin | -7.7% | -7.3% | 13.7% | 12.6% |
| Rev Growth | +1.3% | +1.3% | +20.2% | +12.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 3.64M | 3.64M | 9.02M | 8.61M |
| Total Equity | 8.04M | 8.04M | 15.90M | 15.89M |
| D/E Ratio | 0.45 | 0.45 | 0.57 | 0.54 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.23M | 1.15M | 1.71M | 1.80M |
| Free Cash Flow | — | — | 1.30M | 1.03M |